Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Deciphera Pharmaceuticals Inc (NQ: DCPH )

8.420 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.420
Bid (Size) 8.360 (2)
Ask (Size) 8.710 (13)
Prev. Close 8.420
Today's Range 8.420 - 8.420
52wk Range 7.630 - 52.43
Shares Outstanding 58,041,410
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, announced the presentation of... 
From Business Wire News Releases
Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2022 Corporate Milestones
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today provided a corporate... 
From Business Wire News Releases

Performance

YTD
-24.21%
-24.21%
1 Month
-19.27%
-19.27%
3 Month
-75.15%
-75.15%
6 Month
-73.50%
-73.50%
1 Year
-82.48%
-82.48%

More News

Read More
Deciphera Pharmaceuticals, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
Deciphera Announces Approval of QINLOCK® in the United Kingdom for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
From Business Wire News Releases
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
Tags SMSA JNJ News
From Benzinga
First Week of DCPH July 15th Options Trading
Tags Stocks
From Market News Video
Deciphera Pharmaceuticals Announces Restructuring to Prioritize Clinical Development Programs and Streamline Commercial Operations
From Business Wire News Releases
Analysts See 25% Gains Ahead For FYC
Tags ETFs
From ETF Channel
Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
From Business Wire News Releases
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
Tags Pharma/Biotech Healthcare Market News
From TalkMarkets
Deciphera: Why There Won’t Be a Quick Recovery
Tags Market News DCPH Hot Stocks
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.